GAD(65) IS RECOGNIZED BY T-CELLS, BUT NOT BY ANTIBODIES FROM NOD-MICE

被引:15
作者
BIEG, S [1 ]
SEISSLER, J [1 ]
HERBERG, L [1 ]
NORTHEMANN, W [1 ]
SCHERBAUM, WA [1 ]
机构
[1] UNIV HOSP LEIPZIG,DEPT ENDOCRINOL,JOHANNISALLEE 32,D-04103 LEIPZIG,GERMANY
关键词
TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS; NONOBESE DIABETIC (NOD) MOUSE; AUTOIMMUNITY; T-CELLS; GLUTAMIC ACID DECARBOXYLASE (GAD);
D O I
10.3109/08916939409010653
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Since the 64kDa-protein glutamic acid decarboxylase (GAD) is one of the major autoantigens in T-cell mediated Type 1 diabetes, its relevance as a T-cell antigen needs to be clarified. After isolation of splenic T-cells from non-obese diabetic (NOD) mice, a useful model for human Type 1 diabetes, we found that these T-cells proliferate spontaneously when incubated with human GAD65, but only marginally after incubation with GAD67, both recombinated in the baculovirus system. No effect was observed with non-diabetic NOD mice or with T-cells from H-2 identical NON-NOD-H-2g7 control mice. It has been published previously that NOD mice develop autoantibodies against a 64kDa protein detected with mouse beta cells. In immunoprecipitation experiments with sera from the same NOD mice and S-35-methionine-labelled GAD, no autoantibody binding could be detected. We conclude firstly that GAD65 is an important T-cell antigen which is relevant early in the development of Type 1 diabetes and secondly that there is an antigenic epitope in the human GAD65 molecule recognized by NOD T-cells, but not by NOD autoantibodies precipitating conformational epitopes. Our results therefore provide further evidence that GAD65 is a T-cell antigen in NOD mice, being possibly also involved in very early processes leading to the development of human Type 1 diabetes.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 25 条
[1]  
Eisenbarth G.S., Type 1 Diabetes Mellitus: A chronic autoimmune disease, NEnglJMed, 314, pp. 1360-1368, (1986)
[2]  
Roep B.O., DeVries R.R.P., T lymphocytes and the pathogenesis of type 1 (insulin-dependent) diabetes mellitus, J, Clin. Invest, 22, pp. 1-15, (1992)
[3]  
Roep B.O., Kalian A.A., Hazenbos W.L., Bruining G.J., Baileys E.M., Arden S.D., T-cell reactivity to 38kD insulin secretory granule protein in patients with recent-onset type 1 diabetes, Lancet, 337, pp. 1439-1441, (1991)
[4]  
Baekkeskov S., Aanstoot A.J., Christgau S., Reetz A., Solimena M., Cascalho F., Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthezising enzyme glutamic acid decarboxylase, Nature, 347, pp. 151-156, (1990)
[5]  
Seissler J., Amann J., Mauch L., Haubruck H., Wolfahrt S., Bieg S., Prevalence of autoantibodies to the 65- and 67-kDa isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus, J Clin Invest, 92, pp. 1394-1399, (1993)
[6]  
Solimena M., De Camilli P., Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff Man Syndrome and insulin dependent diabetes mellitus, Trends in Neurosciences, 14, 10, pp. 452-457, (1991)
[7]  
Solimena M., Folli F., Aparisis R., Pozza G., DeCamilli P., Autoantibodies to GABA-ergic neurons and pancreatic beta cells in Stiff Man Syndrome, Engl J Med, 322, 22, pp. 1555-1560, (1991)
[8]  
Christgau S., Aanstoot H.J., Schierbeck H., Bcgley K., Tullin S., Hejnaes K., Membrane anchoring of the autoantigen GAD<sub>65</sub> to microvesicles in pancreatic (3-cells by palmitoyla-tion in the NH2-terminal domain, J Cell Biol, 118, pp. 309-320, (1992)
[9]  
Atkinson M.A., Kaufman D.L., Campbell L., Gibbs K.A., Shah S.C., Bu D., Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes, Lancet, 339, pp. 458-459, (1992)
[10]  
Honeyman M.C., Cram D.S., Harrison L.C., XY1Glutamic acid decarboxylase 67-reactivc T-cells: a marker of insulin-dependent diabetes, J Exp Med, 77, pp. 535-540, (1993)